Title: Study of Morphological Features of Carcinoma of Breast in Relation to ER/PR and Her2/neu Status

Authors: Dr Shikha Ghanghoria, Dr C.S. Chhattrasal, Prof. Dr C.V. Kulkarni, Dr Kundan Singh Sisodiya, Dr Manish Kaushal, Dr Ishrat Jahan

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i6.150

Abstract

Introduction: Breast cancer in India is the most common cancer among women in the urban areas and ranks second in the rural population. In this study our aim is to correlate the morphological features of breast carcinoma with hormone receptor status.

Objectives: To study the morphological features of carcinoma of breast in relation to ER/PR and Her2/neu status.

Materials and Methods: A prospective study conducted from 2016 to 2017 in the Department of Pathology, M.G.M medical college and M.Y Hospital, Indore. 50 cases of carcinoma breast were studied for morphological features and their relation to hormone receptor status.

Results: In present study total 50 patients ranging from 20 to 80 years of age , with 32 (64%)premenopausal and 18 (36%) post menopausal females. Right breast, was most frequently involved (64% cases). Most common size of tumour ranged between 2 to 5cm. Most common histological type of breast carcinoma was invasive ductal carcinoma NOS (not otherwise specified) (90.0%).Both premenopausal and postmenopausal cases showed triple negative as the most common pattern. Among the invasive ductal carcinoma cases, triple negative was the most common pattern. Most common tumour grade in the present study group was grade II and triple negative was the most common pattern in this group.

Conclusion: The breast cancer cases if diagnosed at earlier stage have more favourable prognosis. Increasing the awareness in the public and good programs for early detection of the disease will go a long way in reducing breast cancer.

Keywords: Breast carcinoma, Immunohistochemistry, Morphology and Triple markers.

References

  1. National Cancer Registry Programme, Indian Council of Medical Research. Leading sites of cancer. In, Consolidated Report of Population Based Cancer Registries 2001-2004, Incidence and Distribution of Cancer. Bangalore: Coordinating Unit, National Cancer Registry Programme (ICMR). 2006; 8-30.
  2. Nandakumar A, Ramnath T, Chaturvedi M. The magnitude of cancer breast in India: a summary. Indian J Surg Oncol. 2010; 1:8-9.
  3. Ram Van Der Woodsen. The Problem Prevalence of breast cancer [dissertation]. Philippines 2010.
  4. Whitman G, Sheppard D, Phelps M, BN. G. Breast cancer staging. Semin Roentgenol. 2006;41:91-104.
  5. De Waard, E.A. Baan ders Van Halewijn, J.Huizinga. The bimodal age distribution of patients with mammary carcinoma. Evidence for the existence  of  2 types of human breast cancer. Cancer 1964;(17):141-151.
  6. Lakmini K.B. Mudduwa. Quick  score  of  hormone  receptor  status  of  breast  carcinoma: correlation  with  the  other  clinicopathologic  par ameters.  Indian  Journal  of  Pathology  and Microbiology 2009;52(2):159-163.
  7. Priti lal, Lee K. Tan, Beiyen Chen. Correlation of HER 2 Status  with  Estrogen  and Progesterone Receptors and Histologic features in 3,655 invasive Breast carcinomas. Am J Clin Pathol 2005;123: 541-46.
  8. Mehrdad Nadji, Carmen Gomez Fernandez, Parvin Ganjei  Azar,  Azorides  Moarales. Immunohistochemistry of estrogen and progesterone receptors reconsidered:  Experience with 5993 breast cancers. Am J Clin Pathol 2005;123:21-27.
  9. TB Pathak, R Bashyal, CB Pun  ,S Shrestha, S Bastola, S Neupane  et    Estrogen and progesterone receptor expressor in breast carcinoma. Journal of  pathology and microbiology 2011; 1(2):100-1

Corresponding Author

Dr C. S. Chhattrasal

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.